FDA Approves Lumoxiti
FDA Approves Lumoxiti (moxetumomab pasudotox-tdfk) for Hairy Cell Leukemia
September 13, 2018 -- The U.S. Food and Drug Administration today approved Lumoxiti (moxetumomab pasudotox-tdfk) injection for intravenous use for the treat
Health Tip: Change Poor Posture
-- Everyone has back pain at some point, whether due to poor posture, heavy lifting, a spinal condition present a birth, or an exercise-related injury.
While other triggers for back pain may not be as easy to prevent, poo
FDA Approves Ajovy
FDA Approves Ajovy (fremanezumab-vfrm) for Preventive Treatment of Migraine
September 14, 2018 -- Today, the US Food and Drug Administration (FDA) approved Ajovy (fremanezumab-vfrm) for the preventive treatment of migraine in adults.
Urgent Care Centers Ease ER Burden in U.S.
FRIDAY, Sept. 7, 2018 -- For minor ills such as sore throats, privately insured Americans increasingly use urgent care centers rather than hospital emergency rooms, a new study finds.
Researchers at Brigham a
FDA Approves Tiglutik
ITF Pharma Announces FDA Approval of Tiglutik (riluzole) Oral Suspension for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
BERWYN, Pa., Sept. 6, 2018 /PRNewswire/ -- ITF Pharma, a U.S.-based specialty pharmaceutical company
Health Highlights: Sept. 8, 2018
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Southwest Airlines Passengers May Have Been Exposed to Measles
Passengers and crew on four Southwest Airlines f